Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Forum of Clinical Oncology
Volume 13 (2022): Issue 3 (December 2022)
Open Access
Cancer Heterogeneity and Biomarkers
Athanasios Michas
Athanasios Michas
,
Evangelos Karamitrousis
Evangelos Karamitrousis
,
Nikolaos Tsoukalas
Nikolaos Tsoukalas
and
Michalis Liontos
Michalis Liontos
| Apr 06, 2024
Forum of Clinical Oncology
Volume 13 (2022): Issue 3 (December 2022)
About this article
Previous Article
Next Article
Article
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Article Category:
Editorial
Published Online:
Apr 06, 2024
Page range:
1 - 2
DOI:
https://doi.org/10.2478/fco-2023-0012
© 2023 Athanasios Michas et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Athanasios Michas
Department of Clinical Therapeutics, National and Kapodistrian University of Athens
Greece
Evangelos Karamitrousis
Department of Medical Oncology, Aristotle University of Thesaloniki
Thesaloniki, Greece
Nikolaos Tsoukalas
Department of Oncology,
Athens, Greece
Michalis Liontos
Department of Clinical Therapeutics, National and Kapodistrian University of Athens
Greece